Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith–Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity
Introduction
Genome-scale or “Next Generation” Sequencing (NGS) has become widely available for clinical use. The field of rare and new disease discovery leads the way in the application of NGS, and the NIH Undiagnosed Diseases Program (UDP) typifies this effort. The UDP features intensive phenotyping, diagnostic tools agnostic to disease causation, newly developed NGS analytics, and collaborative research aimed at establishing the disease-causality of candidate mutations by biochemists, cell biologists, and physiologists.
A traditional search for the cause of a heritable disease seeks a single, highly penetrant, large-effect gene. In this model, unusually severe or treatment-refractory presentations represent novel versions of known disorders and are considered to reflect the influence of genetic and/or environmental modifiers. However, case reports support the epidemiologic expectation that multiple rare disorders will occasionally occur in the same individual [1], [2]. Experience in the UDP has confirmed that a substantial number of apparently unique, undiagnosed medical conditions will, in fact, be the combinations of multiple genetic disorders in single individuals or families. Illustrating this, we present a non-consanguineous family with two affected children in which three different functionally verified mutations contribute to their phenotypes. For undiagnosed, unique and extensively investigated individuals such as those evaluated by the UDP, physicians should consider complex alternatives to a single, unifying genetic explanation.
The family reported here included two siblings who presented with variable developmental delay, hypotonia, and fasting hypoglycemia with lactic acidemia. One had prominent dysmorphic features and obesity; the other did not. Each had extensive metabolic and genetic testing by several specialists before the final diagnoses were confirmed by DNA sequencing, functional, and structural analyses.
Section snippets
Patients
The family was enrolled in clinical protocol 76-HG-0238, “Diagnosis and Treatment of Patients with Inborn Errors of Metabolism and Other Genetic Disorders”. The parents gave written informed consent for their children, who were enrolled in the NIH UDP. This initiative evaluates individuals and families in whom previous diagnostic investigations have been unrevealing [3], [4], [5].
NGS sequencing and SNP analysis
SNP oligo array analysis for filtering of exome sequence data was performed using Illumina Bead Array Platform and
Case reports
The propositae are two sisters born to non-consanguineous parents with Ashkenazi Jewish ancestry and a non-contributory family history.
Discussion
This family's unaffected parents had two daughters, each of whom had PEPCK-C deficiency (associated with proven instability of the mutant protein), one of whom had SMS (documented by RAI1 mutation), and the other of whom had a GRIN2B mutation (shown by functional assay of the p.E413G mutation's effect on GluN2B). The SMS explains the dysmorphisms and behavioral phenotype. Mutations in the GRIN2B gene have been associated with a wide range of neurological disorders, including intellectual
Conclusion
In the current era, in which multiple, sophisticated methodologies are employed for molecular diagnostics, more and more families with multiple genetic abnormalities are likely to be ascertained. This challenges the tenet of Occam's razor, i.e., that one explanation should account for all of a patient's symptoms. In particular, our family illustrates the need to consider additional diagnoses for cases that are present in an atypical fashion or are not fully explained by mutation(s) in a single
Acknowledgments
This work was supported by the Intramural Research Program of the National Human Genome Research Institute, by grant NS036654 (S.F.T.); by the NIH Undiagnosed Diseases Program (HSN268201300162P, H.Y.); the Center for Inherited Disorders of Energy Metabolism (D.S.K); the Allison Foundation, grant 116491 (R.W.H.); the National Center for Research Resources Grant P20 RR17708 and the Natural Sciences and Engineering Research Council of Canada (T.H.). Professor Richard W. Hanson died the same day
References (52)
- et al.
Cystic fibrosis co-existing with trisomy 21
J. Cyst. Fibros.
(2010) - et al.
The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases
Genet. Med.
(2012) - et al.
Recombination mapping using Boolean logic and high-density SNP genotyping for exome sequence filtering
Mol. Genet. Metab.
(2012) - et al.
Analysis of relative gene expression data using real-time quantitative PCR and the 2(− Delta Delta C(T)) method
Methods
(2001) - et al.
Molecular pharmacology of human NMDA receptors
Neurochem. Int.
(2012) - et al.
Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse
J. Biol. Chem.
(2007) Thematic minireview series: a perspective on the biology of phosphoenolpyruvate carboxykinase 55 years after its discovery
J. Biol. Chem.
(2009)- et al.
Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries
Cell
(2012) - et al.
Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice
Neuron
(1996) - et al.
The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications
Pharmacol. Ther.
(2003)
Glutamate receptors in the mammalian central nervous system
Prog. Neurobiol.
Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro
Neuron
What is the metabolic role of phosphoenolpyruvate carboxykinase?
J. Biol. Chem.
Triple A syndrome in a patient with genetic growth hormone insensitivity: phenotypic effects of two genetic disorders
Horm. Res. Paediatr.
The NIH Undiagnosed Diseases Program: bonding scientists and clinicians
Dis. Model. Mech.
The NIH Undiagnosed Diseases Program: lessons learned
JAMA
Estimating the degree of identity by descent in consanguineous couples
Hum. Mutat.
Analysis of DNA sequence variants detected by high-throughput sequencing
Hum. Mutat.
Systematic comparison of three genomic enrichment methods for massively parallel DNA sequencing
Genome Res.
Comparative Ct Method
Molecular determinants of coordinated proton and zinc inhibition of N-methyl-d-aspartate NR1/NR2A receptors
Proc. Natl. Acad. Sci. U. S. A.
Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit
J. Neurosci.
Mapping the binding of GluN2B-selective N-methyl-d-aspartate receptor negative allosteric modulators
Mol. Pharmacol.
Scalable molecular dynamics with NAMD
J. Comput. Chem.
Pyruvate carboxylase and phosphoenolpyruvate carboxykinase activity in leukocytes and fibroblasts from a patient with pyruvate carboxylase deficiency
Pediatr. Res.
Systemic deficiency of the first component of the pyruvate dehydrogenase complex
Pediatr. Res.
Cited by (47)
Genotypic and phenotypic spectrum of cytosolic phosphoenolpyruvate carboxykinase deficiency
2022, Molecular Genetics and MetabolismCitation Excerpt :In addition, abnormal ketone levels were reported. While most publications reported ketonuria during hypoglycemia [8,14–16], Vieira et al. interestingly postulated insufficient ketogenesis in PEPCK-C deficiency patients. They found low ketone production relative to high levels of free fatty acids (FFA), and urine organic acids profiles with rare compounds metabolized via secondary pathways as found in deficient ketone production [18].
N-methyl-D-aspartate receptor function in neuronal and synaptic development and signaling
2021, Current Opinion in PharmacologyMapping the Conformational Landscape of Glutamate Receptors Using Single Molecule FRET
2019, Trends in NeurosciencesUnderdiagnoses resulting from variant misinterpretation: Time for systematic reanalysis of whole exome data?
2019, European Journal of Medical GeneticsCitation Excerpt :The main clinical features include hypoglycemia and seizures (Sovik et al., 1975; Vidnes and Sovik, 1976). Reports linking PCK1 pathogenic variations to phenotype presentation have been published (Adams et al., 2014; Santra et al., 2016). For biological interpretation and significance of the variant, the following evidence was considered: (1) a variation in a gene (ExAC pLi: 3.9328e-8) whose associated phenotype is consistent with the patient's phenotype; (2) canonical splice site/loss-of-function variant; (3) variant at extremely low frequency in control databases (gnomAD: allele frequency of 0.00002 and no homozygote found).
Disruption of GRIN2B Impairs Differentiation in Human Neurons
2018, Stem Cell Reports